JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v8i9.8352ArticleTrend Analysis of the Burden of Hypertensive Heart Disease in China from 1990 to 2021https://artdesignp.com/journal/JCNR/8/9/10.26689/jcnr.v8i9.8352YangYanli,LiYing,XiShiliang2024892024-09-26Objective: To quantitatively analyze the burden of hypertensive heart disease (HHD) in China and provide a scientific basis for prevention and control strategies. Methods: Data from the Global Burden of Disease 2021 database were used to assess the disease burden, deaths, years lived with disability (YLDs), and risk factors for HHD in the Chinese population from 1990 to 2021. Results: From 1990 to 2021, HHD cases in China increased from 1.5 million to 3.9 million, with an average annual growth rate of 2.83%. Prevalence rose from 127.76/100,000 to 259.00/100,000, while age-standardized prevalence decreased by 0.68% annually. HHD deaths increased from 232,478 to 320,247, with a mortality rate rise from 19.76/100,000 to 22.56/100,000, though age-standardized mortality decreased by 2.68% annually. YLDs rose from 124,386 to 301,426, with the rate increasing by 2.20% annually, while age-standardized YLDs decreased by 0.67% annually. High sodium intake and low fruit consumption were key risk factors for HHD deaths. Deaths related to low vegetable intake decreased until 2005 and then rose, while deaths from lead exposure showed a similar pattern. Conclusion: HHD cases and prevalence increased significantly, but age-standardized prevalence and mortality rates declined, reflecting the impact of an aging population and improved health interventions. The rise in YLDs highlights the long-term impact on patients’ quality of life. Key risk factors included high sodium intake and low fruit consumption, emphasizing the importance of dietary improvements in HHD prevention. HHD remains a significant public health challenge in China, requiring continuous research and targeted prevention strategies.

Wei J, Mi Y, Li Y, et al., 2021, Factors Associated with Awareness, Treatment and Control of Hypertension Among 3579 Hypertensive Adults in China: Data from the China Health and Nutrition Survey. BMC Public Health, 21: 423. https://doi.org/10.1186/s12889-021-10417-4

Shi Z, Sun X, Yan AF, et al., 2020, Growing Burden of Hypertension in China: Causes, Challenges, and Opportunities. China CDC Wkly, 2(40): 776–779. https://doi.org/10.46234/ccdcw2020.210

Lin H, Wu Y, Wu J, et al., 2022, Prevalence of Hypertension and 10-Year Cardiovascular Disease Risk Among Older Adults Living in Quanzhou, A Coastal Region of Southeast China. Risk Manag Healthc Policy, 15: 1045–1053. https://doi.org/10.2147/RMHP.S341148

Lu M, Li D, Hu Y, et al., 2024, Persistence of Severe Global Inequalities in the Burden of Hypertension Heart Disease from 1990 to 2019: Findings from the Global Burden of Disease Study 2019. BMC Public Health, 24(1): 110. https://doi.org/10.1186/s12889-023-17573-9

GBD 2019 Chronic Respiratory Diseases Collaborators, 2023, Global Burden of Chronic Respiratory Diseases and Risk Factors, 1990–2019: An Update from the Global Burden of Disease Study 2019. EClinicalMedicine, 59: 101936. https://doi.org/10.1016/j.eclinm.2023.101936

Lu WL, Yuan JH, Liu ZY, et al., 2024, Worldwide Trends in Mortality for Hypertensive Heart Disease from 1990 to 2019 with Projection to 2034: Data from the Global Burden of Disease 2019 Study. Eur J Prev Cardiol, 31(1): 23–37. https://doi.org/10.1093/eurjpc/zwad262

The Writing Committee of the Report on Cardiovascular Health and Diseases in China, Hu SS, 2023, Report on Cardiovascular Health and Diseases in China 2021: An Updated Summary. J Geriatr Cardiol, 20(6): 399–430. https://doi.org/10.26599/1671-5411.2023.06.001

Wang H, Chai K, Du M, et al., 2021, Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis. Circ Heart Fail, 14(10): e008406. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008406

Wang Z, Ma L, Liu M, et al., 2023, Summary of the 2022 Report on Cardiovascular Health and Diseases in China. Chin Med J (Engl), 136(24): 2899–2908. https://doi.org/10.1097/CM9.0000000000002927

Xu D, Hu J, Wang S, et al., 2022, Trends in the Prevalence of Hypertensive Heart Disease in China From 1990 to 2019: A Joinpoint and Age-Period-Cohort Analysis. Front Public Health, 10: 833345. https://doi.org/10.3389/fpubh.2022.833345

Zhang Y, Sun Q, Yu C, et al., 2024, Associations of Traditional Cardiovascular Risk Factors with 15-Year Blood Pressure Change and Trajectories in Chinese Adults: A Prospective Cohort Study. Journal of Hypertension, 42(8): 1340–1349. https://doi.org/10.1097/HJH.0000000000003717

Lu Y, Wang P, Zhou T, et al., 2018, Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States. J Am Heart Assoc, 7(3): e007462. https://doi.org/10.1161/JAHA.117.007462

Chen X, Jin H, Wang D, et al., 2023, Serum Creatinine Levels, Traditional Cardiovascular Risk Factors and 10-Year Cardiovascular Risk in Chinese Patients with Hypertension. Front Endocrinol (Lausanne), 14: 1140093. https://doi.org/10.3389/fendo.2023.1140093

Chen X, Tu Q, Wang D, et al., 2023, Effectiveness of China-PAR and Framingham Risk Score in Assessment of 10-Year Cardiovascular Disease Risk in Chinese Hypertensive Patients. Public Health, 220: 127–134. https://doi.org/10.1016/j.puhe.2023.05.007

Peng X, Wang J, Li J, et al., 2023, Gender-Specific Prevalence and Trend of Heart Failure in China from 1990 to 2019. ESC Heart Fail, 10(3): 1883–1895. https://doi.org/10.1002/ehf2.14361